查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1968570

儿童过敏诊断市场－全球产业规模、份额、趋势、机会和预测：按过敏原、产品、检测方法、地区和竞争对手划分，2021-2031年

Pediatric Allergy Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Allergen, By Product, By Test, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球儿童过敏诊断市场预计将从 2025 年的 25.3 亿美元大幅成长至 2031 年的 47.3 亿美元，复合年增长率为 10.99%。

此领域涵盖多种专门用于检测婴幼儿和青少年过敏易感性的临床检测和程序，例如特异性IgE血液检测、皮肤点刺试验和口服食物激发试验。推动该市场发展的主要因素是全球儿童过敏性疾病（尤其是气喘和食物过敏）盛行率的不断上升，使得早期准确检测对于避免严重的健康后果至关重要。此外，饮食习惯的改变和日益严重的环境污染也加剧了特异性疾病的发生率，进一步增加了对有效诊断方法的需求。根据食物过敏研究与教育基金会2024年的患者登记数据，46%的食物过敏患者曾发生过敏性休克，凸显了开发可靠诊断工具以应对日益增长的临床负担的紧迫性。

市场概览
预测期 2027-2031
市场规模：2025年 25.3亿美元
市场规模：2031年 47.3亿美元
复合年增长率：2026-2031年 10.99%
成长最快的细分市场 食物
最大的市场 北美洲

儘管市场呈现成长态势，但先进诊断设备的高成本仍是市场扩张的主要障碍，限制了资源匮乏地区获得这些服务的机会。专业检测平台所需的大量资金，加上开发中国家训练有素的儿童过敏专家短缺，阻碍了这些关键医疗解决方案的广泛应用。这些因素限制了经济条件较差地区获得必要的过敏诊断服务，对全球市场的渗透构成了明显的障碍。

市场驱动因素

全球儿童过敏性疾病发生率的激增是儿童过敏诊断市场的主要驱动力。为了应对日益增多的临床病例，需要强大的检测能力。这种增长在呼吸系统疾病和食物过敏领域尤其显着，早期发现对于预防慢性健康问题和危及生命的过敏性休克至关重要。随着盛行率的上升，医疗保健系统正致力于开发精准的筛检工具，以区分真正的过敏和超敏反应。根据气喘与过敏基金会于2025年4月发布的最新版《过敏状况与统计》报告，美国约有400万名儿童（占儿童人口的5.8%）被诊断为食物过敏。这一人口趋势正在推动诊断能力的市场扩张，以确保对弱势儿童群体进行快速且准确的干预。

同时，自动化检测解决方案和先进的成分降解诊断 (CRD) 技术的整合正在改变市场。这些技术比传统的全过敏原萃取物具有更高的准确性，使临床医生能够精确识别特定的过敏原蛋白成分。这最大限度地减少了假阳性结果，并有助于实施标靶免疫疗法。例如，Leviti 在 2025 年 5 月的新闻稿中宣布推出其全自动 IDS i20 平台，该平台能够处理涵盖过敏等多个诊断领域的 20 个分析参数，从而优化检查室工作流程。这项技术进步得到了业界的大力投资支持。赛默飞世尔科技 (Thermo Fisher Scientific) 在 2025 年 10 月发布的 2025 年第三季财报中报告称，其收入增长了 5%，达到 111.2 亿美元，这凸显了持续的经济成长势头，推动了这些诊断设备的广泛应用。

市场挑战

先进诊断设备的高昂成本是全球儿童过敏诊断市场成长的主要障碍。这项经济负担严重限制了开发中国家和医疗预算有限的资源匮乏地区采用必要的检测平台。因此，这些地区的医疗机构往往无法负担精准口服食物激发试验和特异性IgE血液检测所需的专业设备。这种准入障碍阻碍了市场向易患特应性疾病的高危险群渗透，抑制了潜在的收入来源，并减缓了全球扩张。

人力和财力方面的限制导致缺乏可及的高品质诊断方法，从而严重影响了市场效率和患者照护。当先进的诊断工具无法获得或价格过高时，医疗服务提供者被迫依赖准确性较低的方法，导致临床疗效欠佳，并进一步减少了对该领域的投资。据欧洲过敏与临床免疫学会称，到2024年，欧盟约有45%的过敏患者可能被误诊，这凸显了这些持续存在的准入障碍导致现有市场基础设施​​在有效评估和接触患者方面存在重大缺陷。

市场趋势

人工智慧 (AI) 与精准诊断的融合正在迅速重塑全球儿童过敏诊断市场，简化工作流程并规范临床评估结果的解释。与容易出现观察者间差异的传统人工皮肤点刺试验判读相比，新兴的 AI 驱动演算法能够对风团反应进行客观、自动化的分析，从而提高儿童人群诊断的一致性。这项技术透过简化评估流程直接解决了临床瓶颈问题，使医疗服务提供者能够更有效地处理更多患者。根据发表于 2024 年 10 月《欧洲公共卫生杂誌》的论文《AI 增强型过敏诊断》，一项涉及约 300 名患者的临床试验表明，AI 辅助诊断使过敏科医生平均每位患者的诊疗时间减少了 40 分钟，显着减轻了过敏治疗中的人力负担。

同时，市场正经历一场技术变革，体外诊断方法正逐渐取代高风险的体内检测，例如口服食物激发试验。目前正在开发新的功能性检测方法，这些方法能够在受控的实验室环境中模拟过敏反应，为诊断儿童和婴儿的复杂食物过敏提供了一种安全有效的选择，避免了过敏性休克的风险。这些先进的体外诊断技术透过测量细胞对特定过敏原的实际反应，提高了诊断准确性，优于标准的IgE检测。例如，伯恩大学在2024年10月的新闻稿中宣布，研究人员开发了一种新的体外诊断方法—“Hoxb8肥大细胞活化检测”，在儿童花生过敏病例中实现了95%的诊断准确率。这项结果超越了传统血液检测和皮肤试验的可靠性。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球儿童过敏诊断市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依过敏原分类（食物、吸入性过敏原、其他过敏原）
    • 依产品（设备、服务）分类
    • 依测试类型（体外测试、体外测试）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美儿童过敏诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲儿童过敏诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区儿童过敏诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲儿童过敏诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲儿童过敏诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球儿童过敏诊断市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • bioMerieux SA
  • Thermo Fisher Scientific, Inc
  • Stallergenes Greer
  • Minaris Medical America Inc.
  • Siemens Healthineers AG
  • Cambridge Nutritional Sciences Plc（Omega Diagnostics Ltd）
  • R-Biopharm AESKU.GROUP GmbH & Co. KG
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HYCOR Biomedical
  • Lincoln Diagnostics, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 25354

The Global Pediatric Allergy Diagnostics Market is projected to expand significantly, rising from a valuation of USD 2.53 billion in 2025 to USD 4.73 billion by 2031, reflecting a compound annual growth rate of 10.99%. This sector encompasses various clinical assays and procedures, including specific IgE blood analysis, skin prick testing, and oral food challenges, which are specifically tailored to detect allergic sensitivities in infants and adolescents. The primary force driving this market is the escalating global prevalence of pediatric allergic conditions, particularly asthma and food allergies, creating a critical need for early and precise detection to avert severe health consequences. Furthermore, shifting dietary habits and increasing environmental pollution are contributing to a higher incidence of atopic diseases, thereby intensifying the demand for effective diagnostic mechanisms. Data from the Food Allergy Research & Education patient registry in 2024 revealed that 46% of individuals with food allergies suffered from anaphylaxis, highlighting the urgent necessity for reliable diagnostic tools to address this mounting clinical burden.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.53 Billion
Market Size 2031USD 4.73 Billion
CAGR 2026-203110.99%
Fastest Growing SegmentFood
Largest MarketNorth America

Despite this growth trajectory, market expansion faces a substantial obstacle due to the high costs linked to advanced diagnostic instrumentation, which curtails accessibility in regions with limited resources. The significant financial outlay required for specialized testing platforms, combined with a scarcity of trained pediatric allergists in developing economies, impedes the widespread adoption of these vital healthcare solutions. These factors create a distinct barrier to global market penetration, restricting the availability of essential allergy diagnostics in areas where economic constraints prevail.

Market Driver

The surging global incidence of pediatric allergic conditions acts as the main engine for the pediatric allergy diagnostics market, requiring strong testing frameworks to handle growing clinical caseloads. This increase is especially notable in respiratory conditions and food allergies, where early detection is vital to prevent chronic health issues and life-threatening anaphylactic events. As prevalence rates rise, healthcare systems are focusing on accurate screening tools to distinguish between true allergies and sensitivities. According to the 'Allergy Facts and Figures' update released by the Asthma and Allergy Foundation of America in April 2025, approximately 4 million children in the United States, accounting for 5.8% of the pediatric population, have received a food allergy diagnosis. This demographic trend compels the market to broaden its diagnostic capabilities, ensuring timely and exact interventions for vulnerable pediatric groups.

Concurrently, the market is being transformed by the integration of automated laboratory solutions and advanced component-resolved diagnostic (CRD) technologies, which provide greater precision than traditional whole-allergen extracts. These innovations allow clinicians to pinpoint specific allergenic protein components, thereby minimizing false positives and facilitating targeted immunotherapy. For example, Revvity, Inc. announced in a May 2025 press release the launch of its IDS i20 platform, a fully automated system capable of processing 20 analytes across various diagnostic specialties, including allergy, to optimize laboratory workflows. This technological progression is bolstered by significant industry investment; Thermo Fisher Scientific reported in its 'Third Quarter 2025 Results' in October 2025 that revenue increased by 5% to $11.12 billion, underscoring the continued economic momentum that supports the broad deployment of these diagnostic instruments.

Market Challenge

The substantial expense linked to advanced diagnostic instrumentation serves as a formidable impediment to the growth of the global pediatric allergy diagnostics market. This financial load severely restricts the uptake of essential testing platforms in developing economies and resource-constrained regions where healthcare budgets are frequently limited. As a result, medical facilities in these locations often cannot afford the specialized equipment necessary for precise oral food challenges or specific IgE blood analysis. This lack of accessibility hinders the market from reaching extensive, high-population demographics that are increasingly prone to atopic diseases, thereby suppressing potential revenue streams and stalling global expansion.

The scarcity of accessible, high-quality diagnostics stemming from these workforce and financial limitations creates a significant deficit in market efficiency and patient care. When sophisticated tools are unavailable or unaffordable, healthcare providers are forced to depend on less accurate methods, resulting in suboptimal clinical outcomes that further discourage investment in the sector. According to the European Academy of Allergy and Clinical Immunology, approximately 45% of allergy patients within the European Union were likely misdiagnosed in 2024, emphasizing the critical failure of the existing market infrastructure to effectively evaluate and reach patients due to these persistent barriers to access.

Market Trends

The incorporation of artificial intelligence into precision diagnosis is swiftly reshaping the Global Pediatric Allergy Diagnostics Market by optimizing workflow efficiency and standardizing clinical assessment interpretations. In contrast to traditional manual readings of skin prick tests, which are prone to inter-observer variability, emerging AI-driven algorithms facilitate the objective, automated analysis of wheal reactions, thereby improving diagnostic consistency among pediatric populations. This technological adoption directly resolves clinical bottlenecks by streamlining evaluation processes, enabling healthcare providers to handle larger patient volumes more effectively. As reported in the 'AI-Enhanced Allergy Diagnostics' article by the European Journal of Public Health in October 2024, clinical trials with approximately 300 patients showed that AI-supported diagnostics cut the time needed for allergists by an average of 40 minutes per patient, significantly alleviating workforce pressures in allergy clinics.

Concurrently, the market is undergoing a major technological transition toward in vitro diagnostic modalities intended to supersede high-risk in vivo procedures such as oral food challenges. Novel functional assays are being developed to replicate allergic reactions within a controlled laboratory setting, providing a safer option for diagnosing complex food sensitivities in children and infants without the danger of triggering anaphylaxis. These advanced in vitro techniques offer enhanced diagnostic performance relative to standard IgE testing by gauging actual cellular responses to specific allergens. For instance, the University of Bern announced in an October 2024 press release regarding the 'Hoxb8 mast cell activation test' that researchers had created a new in vitro diagnostic method achieving 95% diagnostic accuracy in pediatric peanut allergy cases, exceeding the reliability of traditional blood and skin tests.

Key Market Players

  • bioMerieux SA
  • Thermo Fisher Scientific, Inc
  • Stallergenes Greer
  • Minaris Medical America Inc.
  • Siemens Healthineers AG
  • Cambridge Nutritional Sciences Plc(Omega Diagnostics Ltd)
  • R-Biopharm AESKU.GROUP GmbH & Co. KG
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HYCOR Biomedical
  • Lincoln Diagnostics, Inc.

Report Scope

In this report, the Global Pediatric Allergy Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pediatric Allergy Diagnostics Market, By Allergen

  • Food
  • Inhaled Drug
  • Other Allergens

Pediatric Allergy Diagnostics Market, By Product

  • Instruments
  • Services

Pediatric Allergy Diagnostics Market, By Test

  • In vivo Test
  • In vitro Test

Pediatric Allergy Diagnostics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pediatric Allergy Diagnostics Market.

Available Customizations:

Global Pediatric Allergy Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pediatric Allergy Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Allergen (Food, Inhaled Drug, Other Allergens)
    • 5.2.2. By Product (Instruments, Services)
    • 5.2.3. By Test (In vivo Test, In vitro Test)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Pediatric Allergy Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Allergen
    • 6.2.2. By Product
    • 6.2.3. By Test
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pediatric Allergy Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Allergen
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Test
    • 6.3.2. Canada Pediatric Allergy Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Allergen
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Test
    • 6.3.3. Mexico Pediatric Allergy Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Allergen
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Test

7. Europe Pediatric Allergy Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Allergen
    • 7.2.2. By Product
    • 7.2.3. By Test
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pediatric Allergy Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Allergen
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Test
    • 7.3.2. France Pediatric Allergy Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Allergen
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Test
    • 7.3.3. United Kingdom Pediatric Allergy Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Allergen
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Test
    • 7.3.4. Italy Pediatric Allergy Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Allergen
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Test
    • 7.3.5. Spain Pediatric Allergy Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Allergen
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Test

8. Asia Pacific Pediatric Allergy Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Allergen
    • 8.2.2. By Product
    • 8.2.3. By Test
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pediatric Allergy Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Allergen
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Test
    • 8.3.2. India Pediatric Allergy Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Allergen
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Test
    • 8.3.3. Japan Pediatric Allergy Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Allergen
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Test
    • 8.3.4. South Korea Pediatric Allergy Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Allergen
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Test
    • 8.3.5. Australia Pediatric Allergy Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Allergen
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Test

9. Middle East & Africa Pediatric Allergy Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Allergen
    • 9.2.2. By Product
    • 9.2.3. By Test
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pediatric Allergy Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Allergen
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Test
    • 9.3.2. UAE Pediatric Allergy Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Allergen
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Test
    • 9.3.3. South Africa Pediatric Allergy Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Allergen
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Test

10. South America Pediatric Allergy Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Allergen
    • 10.2.2. By Product
    • 10.2.3. By Test
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pediatric Allergy Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Allergen
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Test
    • 10.3.2. Colombia Pediatric Allergy Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Allergen
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Test
    • 10.3.3. Argentina Pediatric Allergy Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Allergen
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Test

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pediatric Allergy Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. bioMerieux SA
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific, Inc
  • 15.3. Stallergenes Greer
  • 15.4. Minaris Medical America Inc.
  • 15.5. Siemens Healthineers AG
  • 15.6. Cambridge Nutritional Sciences Plc(Omega Diagnostics Ltd)
  • 15.7. R-Biopharm AESKU.GROUP GmbH & Co. KG
  • 15.8. EUROIMMUN Medizinische Labordiagnostika AG
  • 15.9. HYCOR Biomedical
  • 15.10. Lincoln Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer